Therapeutic Candidates from Plants and the Pharmacology of Their Effects on Atopic Dermatitis
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: closed (15 February 2023) | Viewed by 10783
Special Issue Editor
Special Issue Information
Dear Colleagues,
Atopic dermatitis (AD), a representative disease of eczema, causes severe itching and deterioration of the skin barrier caused by a combination of external stimuli (allergens) and chronic inflammation that trigger symptoms, and AD is generally induced or its progress facilitated by T cell-mediated chronic inflammation, involving various immune cells and mediators.
Although steroids (local, systemic) and immunomodulatory agents are used clinically, synthetic drugs are known to have significant side effects following long-term use. Natural products from plant sources, which are generally safer than synthetics, have been investigated in developing therapeutic candidates for AD treatment that suppress the activation inflammatory events in the skin.
This Special Issue has the purpose of introducing the latest research on natural compounds and extracts as potential drug candidates in addition to suggesting future directions for the development of AD therapeutics.
Prof. Dr. Sei-Ryang Oh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atopic dermatitis
- skin barrier
- inflammation
- cytokine
- anti-inflammation
- phytochemical
- natural product
- plant source
- therapeutic candidate
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.